BioElectronics Corporation' ActiPatch Pain Therapy Expands Into Costco Canada
FREDERICK, Md., Nov. 19, 2015 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Canadian distributor has received its initial orders for its ActiPatch® Pain Relief products from Costco's online store, http://www.costco.ca/CatalogSearch?storeId=10302&catalogId=11201&langId=-24&refine=&keyword=actipatch.
Chris Russell, President, Chris-Kelly, LLC, the Canadian distributor, stated, "This product placement in a local major retailer establishes product credibility. Potential users and 7-Day Trial testers take comfort knowing that the product has been vetted locally. We look forward to providing Canadians this unique chronic pain therapy."
About Costco Canada
Costco serves more than 10 million members across Canada, and is one of the nation's largest retailers, averaging CDN$16 billion ($12 billion US) in sales per year. As a membership group, Costco is selective in product selection to be sure their members receive quality goods and services at the lowest possible prices. Costco warehouses carry about 4,000 SKUs (stock keeping units) compared to the 30,000 found at most supermarkets. By carefully choosing products based on quality, price, brand, and features, the company can offer the best value to members.
About BioElectronics Corporation
BioElectronics Corporation is the maker of a leading family of affordable, disposable, drug-free, medical devices. ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; HealFast® Therapy and the Allay® Menstrual Pain Therapy. Please visit www.bielcorp.com for more information.
Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bioelectronics-actipatch-pain-therapy-expands-into-costco-canada-300181365.html
SOURCE BioElectronics Corporation
